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Purpose: Internal radiation dosimetry plays an important role in ensuring the safe use of 25 
positron emission tomography (PET) technology and is a legal requirement in most countries. 
We propose a new technique to estimate the internal radiation dose in PET studies by means 
of multiple D-shuttle dosimeters attached on the body surface of the patient. 
Methods:  Radioactivity in a source organ was estimated iteratively using measurements from 
multiple D-shuttle dosimeters with a maximum-likelihood expectation-maximization (MLEM) 30 
algorithm with dose response from a source to a D-shuttle dosimeter computed by Monte 
Carlo simulation. To validate our technique, we performed a phantom study using a National 
Electrical Manufacturers Association (NEMA) body phantom. The fillable compartments 
(torso cavity and six spheres) of the phantom were filled with 18F-FDG mixed with pure water 
using an 800:1 sphere-to-background radioactivity concentration ratio. The radioactivity 35 
concentrations present in the torso cavity and six spheres were 0.00165 MBq/mL and 1.32 
MBq/mL, respectively. The initial radioactivities of the torso cavity and six spheres (treated as 
source organs) were 15.9 MBq (torso cavity), 34.7 MBq (37 mm sphere), 15.1 MBq (28 mm 
sphere), 7.27 MBq (22 mm sphere), 3.26 MBq (17 mm sphere), 1.54 MBq (13 mm sphere), 
and 0.697 MBq (10 mm sphere). Eleven D-shuttle dosimeters were attached to the NEMA 40 
body phantom surface to obtain information on body surface dose and a mathematical NEMA 
body phantom has been modelled in the Heavy Ion Transport Code System (PHITS) Monte 
Carlo simulation code.  
Results: Radioactivity was estimated in two minute intervals over a 110-min total dose time 
using our proposed technique. A significant correlation (R2 = 0.992) was found between actual 45 
radioactivity and estimated radioactivity at every two minute interval for each source organ. 
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The estimated initial radioactivity (mean with standard deviation) was 16.5 ± 0.311 MBq 
(torso cavity), 33.0 ± 0.624 MBq (37 mm sphere), 15.7 ± 0.189 MBq (28 mm sphere), 7.11 ± 
0.738 MBq (22 mm sphere), 4.17 ± 0.083 MBq (17 mm sphere), 1.48 ± 0.469 MBq (13 mm 
sphere), and 0.865 ± 0.313 MBq (10 mm sphere), which were very close to the actual initial 50 
radioactivity measurements for each source organ. 
Conclusions: The phantom study showed that our technique worked successfully. This 
technique could be used to estimate internal radiation dosimetry in a clinical PET study.  
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1. INTRODUCTION  
Positron emission tomography (PET) is an important radioisotope imaging modality in 
nuclear medicine for the diagnosis, prognosis, staging, treatment response monitoring, and 60 
radiation therapy planning for a wide range of malignancies1,2. A large amount of radioactivity 
is administrated for the examinee when acquiring functional information on a patient during 
a PET examination, although the half-life of the radioactivity is very short2,3. Because of the 
harmful effect of ionizing radiation, a patient’s radiation exposure is becoming a concerning 
issue during PET examinations4. Internal radiation dosimetry in nuclear medicine is a very 65 
important procedure for balancing the potential risks from radiation exposure during a PET 
examination against its benefits5. The Medical Internal Radiation Dose (MIRD) facilitates the 
problem of assessing internal radiation doses by providing models, methodologies, and 
schema. The MIRD computational method simplifies the calculation of radiation doses for 
specified target organs from the cumulative radioactivities in source organs and the so-called 70 
S-values from the source organ to the target organ6. The source organs are radioactive, and 
the target organ is the organ in which the dose is calculated, and the target and source organs 
can be the same organ. The S-value is the radiation dose in the target organ per unit of 
cumulative radioactivity in the source organ, which can be calculated using an MIRD reference 
phantom and a Monte Carlo simulation, and the cumulative radioactivity in a source organ is 75 
the total number of radioactive decays during the time the source organ is radioactive. For 
purposes of internal radiation dose calculation, and due to the required computational 
characteristics, family anthropomorphic mathematical phantoms associated with Monte 
Carlo simulations have been developed by the Oak Ridge National Laboratory (ORNL), and 
these phantoms are categorized as MIRD reference phantoms7,8. Finally, the radiation dose 80 
of the target organ can be estimated from the cumulative radioactivities in the source organs 
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by using computer software, such as the MIRDOSE software9, OLINDA/EXM software10, 
SPRIND Software 11, Hybrid Dosimetry software12, etc. 
There are a few conventional methods which have been applied to estimate 
cumulative radioactivities in the source organs of a patient in nuclear medicine. Cumulative 85 
radioactivities in source organs have been estimated using the classical tissue dissection 
method in animal species such as rodents, dogs, rabbits, and non-human primates; these 
estimates were later extended to humans13,14,15,16. After intravenously injecting animal 
species with a radiopharmaceutical, the animals were euthanized by cervical dislocation at 
several time points, and the major tissues have been harvested, weighed, and the tissue 90 
uptake is calculated as the percent injected dose per gram of tissue (%ID/g). Then, tissue 
uptake data has been extrapolated to a reference human body phantom using the %kg/gm 
method to estimate the cumulative radioactivity in human source organs17 . This conventional 
ex vivo tissue dissection method requires a large number of animals to obtain cumulative 
radioactivities in source organs for dosimetry calculation15,18. Human data predicted on the 95 
basis of animal species data is also inaccurate. The large metabolic differences with respect 
to the administrated radiopharmaceuticals, interspecies differences in pharmacokinetics, 
differences in the amount of injected radioactivity, differences in anesthetic protocols, and 
methodological differences are the primary factors for the resulting inconsistencies between 
extrapolation from animal data and real human data in internal radiation dosimetry19,20,21.  In 100 
the last decade, a repeated whole body PET imaging method was used to estimate the 
cumulative radioactivity in the source organ from internally administrated radioactivity in 
humans and has been widely applied in nuclear medicine20,22,23. Whole-body PET images have 
been reconstructed with attenuation and scattering corrections. Three-dimensional volumes 
of interest (VOIs) have been manually drawn on multiple slices of PET images, where the 105 
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organ is used to form time activity curves (TAC) for calculating cumulative radioactivity in the 
source organ. Because sophisticated imaging protocols and sufficient data are required to 
form TACs, a series of whole-body PET scans at different times are required to obtain an 
internal radiation dosimetry estimation, which is difficult to perform routinely and takes much 
longer than usual clinical PET studies; this can make the patient uncomfortable 22,24. Therefore, 110 
TAC measurement for estimating cumulative radioactivities in a patient’s source organs by 
repeated whole body PET scans is time consuming and expensive25. 
As an alternative to these aforementioned conventional methods, Matsumoto et al.5 
has proposed a method to estimate internal dosimetry through the external measurements 
with thermoluminescent dosimeters (TLDs).  In this method, a number of TLD are attached to 115 
the patient' body surface during a PET study to obtain information on body surface doses, as 
these doses are connected to cumulative radioactivities in multiple source organs considering 
gamma ray contributions. The R-matrix (i.e., S-value) is then calculated by a Monte Carlo 
simulation26 with an MIRD mathematical phantom. Cumulative radioactivities of the source 
organs have been estimated by solving the dose-radioactivity equation from the R-matrix and 120 
the body surface dose by using the mathematical inverse transform method27. Recently 
Cheng-Chang Lu et al.25 have proposed an advanced TLD method to obtain TAC data from 
fractional cumulative radioactivities in a source organ, and they performed validation studies 
on physical phantoms. In this method, serial body surface dose measurements at different 
time periods with several sets of TLDs are placed on the body surface and used to estimate 125 
the fractional cumulative radioactivities in each organ for each time period using Monte Carlo 
simulation, a patient-specific dosimetry system (SimDOSE)28, and the Jacobi linear inverse 
method. In their validation study, body surface doses have been measured three times at 
three time periods by using three sets of TLDs. This study is impractical and time consuming. 
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Because TLD measurements can usually be obtained during a one-hour clinical PET study, 130 
cumulative radioactivities have only been estimated for that time period. The contribution of 
residual cumulative radioactivities for an infinite time period have been extrapolated by 
assuming that biological excretion and uptake is negligible, and only physical decay dominates. 
This TLD measurement dose data based on a single time point is not sufficient for estimating 
realistic cumulative radioactivities in source organs.  135 
Here, we propose a technique for estimating cumulative radioactivity in the source 
organ of a patient using D-shuttle dosimeters. D-shuttle is a semiconductor dosimeter which 
has been used for purposes of continuous long-term personal dose monitoring of residents in 
the area affected by the Fukushima Daiichi nuclear power plant accident in 2011, which was 
caused by the great east Japan earthquake and tsunami29,30,31. A small number of D-shuttle 140 
dosimeters will be attached to the patient body surface to obtain dose information from 
several source organs. Radioactivities in the source organs will be calculated by solving the 
dose-radioactivity formula iteratively using body surface doses as measured by the D-shuttle 
dosimeter and R-matrix. We utilized the maximum-likelihood expectation-maximization 
(MLEM) algorithm32 to solve the dose-radioactivity formula. Since a D-shuttle dosimeter gives 145 
data every two minutes and can be read out by a computer interface31, the radioactivity in a 
source organ at two minute intervals can be easily estimated by our proposed technique. The 
cumulative radioactivity in a source organ then can be calculated from the radioactivity at 
two minute intervals. Moreover, we can easily obtain sufficient data from the D-shuttle 
dosimeter measurement during the PET study, and then these data can be extrapolated for 150 
the required time period to estimate the residual cumulative radioactivity in the organs.  
In the present study, we validate our proposed method using a NEMA body phantom 
experiment with 18F-FDG PET radiotracer.  
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2. MATERIALS AND METHODS  
2.A. D-shuttle Dosimeter 155 
D-shuttle is a simple, reliable, durable, low-priced, and user friendly personal gamma 
ray dosimeter which was produced by Chiyoda Technol Corporation, Japan29,30 (Figure 1). This 
new dosimetry system includes a Si diode-based dosimeter, a pocket reader, a table reader 
connectable via USB cable to a PC, and a complementary software application.  It is capable 
of logging the integrated dose every hour in an internal memory with time stamps. Dose 160 
measurements (the personal dose equivalent at a depth of 10 mm, Hp(10)) can displayed on 
a computer, and a dedicated workstation displays the dose graphically for easy analysis31 .  
One should note that the manufacturer has customized the dosimeter for obtaining sufficient 
dose data in two minute intervals. Various D-shuttle dosimeter features described by the 
manufacturer are listed in Table 129,30,31. Z Čemusová et al.30 tested the dosimetric 165 
characteristics of D-shuttle related to Hp(10) measurements, energy dependency, angular 
dependency, etc., and reported that most of the results were in agreement with the 
manufacturer’s specifications.  
 
2.B. Medical Internal Radiation Dose (MIRD) method 170 
The internal radiation dosimetry formulation has been adopted by the MIRD 
computational methodology and simplifies radiation dose calculations for specified target 
organs (Figure 2) 5,6. Doses due to radioactive decay in source organs are expressed by the 
following formula: 
                 𝐷𝐷𝑖𝑖 = 𝑆𝑆𝑖𝑖,1. ?̃?𝐴1 + 𝑆𝑆𝑖𝑖,2. ?̃?𝐴2 + 𝑆𝑆𝑖𝑖,3. ?̃?𝐴3 + ⋯ 175 
         = ∑ 𝑆𝑆𝑖𝑖,𝑗𝑗. ?̃?𝐴𝑗𝑗𝑗𝑗 .                                                                                                                          (1) 
The cumulative radioactivity in the jth source organ33 is 
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                 ?̃?𝐴𝑗𝑗 = ∫ 𝐴𝐴(𝑡𝑡) 𝑑𝑑𝑡𝑡
∞
0 .                                                                                                                     (2) 
A(t) is the present radioactivity in the jth source organ, Di is the radiation dose in the 
ith target organ, and 𝑆𝑆𝑖𝑖,𝑗𝑗  is the radiation dose in the ith target organ per unit cumulative 180 
radioactivity in the jth source organ. This equation can also be expressed by the following 
matrix equation: 










𝑆𝑆1,1 𝑆𝑆1,2   ⋯ 𝑆𝑆1,𝑗𝑗
𝑆𝑆2,1 𝑆𝑆2,2   ⋯ 𝑆𝑆2,𝑗𝑗
⋮      ⋮     ⋱     ⋮














                                                                                     (3)   
 
2.C. Proposed Technique 185 
A flow chart of our proposed technique for estimating internal radiation dose in PET 
studies is shown in Figure 3. Replacing the term target organ by the D-shuttle dosimeter 
position, we proposed a similar technique for estimating cumulative radioactivities in a 
patient’s source organs (Figure 4). The body surface dose at the D-shuttle dosimeter position 
can be facilitated by the sum of contributions from each source organ and is expressed by  190 
           𝑑𝑑𝑖𝑖(𝑡𝑡) = 𝑅𝑅𝑖𝑖,1.𝐴𝐴1(𝑡𝑡) + 𝑅𝑅𝑖𝑖,2.𝐴𝐴2(𝑡𝑡) + 𝑅𝑅𝑖𝑖,3.𝐴𝐴3(𝑡𝑡) 
                = ∑ 𝑅𝑅𝑖𝑖,𝑗𝑗 .𝐴𝐴𝑗𝑗(𝑡𝑡)𝑗𝑗 .                                                                                                                            (4) 
where di(t) is the body surface dose at the ith D-shuttle dosimeter position at time t, 𝐴𝐴𝑗𝑗(𝑡𝑡) is 
the radioactivity at time t in the jth source organ, and Ri,j is radiation dose at the ith D-shuttle 
dosimeter position per unit cumulative radioactivity in the jth source organ. This equation can 195 
also be expressed by the following matrix equation: 






𝑅𝑅1,1 𝑅𝑅1,2   ⋯ 𝑅𝑅1,𝑗𝑗
𝑅𝑅2,1 𝑅𝑅2,2   ⋯ 𝑅𝑅2,𝑗𝑗
⋮      ⋮     ⋱     ⋮






�                                                                                 (5)                       
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The body surface doses at time t at the ith D-shuttle dosimeter position di(t) can be 
obtained from the D-shuttle dosimeter attachment on the patient body surface, and Ri,j can 
be calculated by a Monte Carlo simulation. The R-value can be determined based on the 200 
photon energy fluence and the mass energy absorption coefficient as expressed by the 
following formula34: 
         𝑅𝑅 = 𝛴𝛴𝛴𝛴(𝐸𝐸)(μen(E)
𝜌𝜌
)                                                                                                                    (6)    
𝛴𝛴(𝐸𝐸) is the photon fluence as a function of energy per unit cumulative radioactivity in the 
source organ, and μenρ−1 is the mass energy absorption coefficient. The mass energy 205 
absorption coefficient can be taken from the International Commission on Radiation Units 
and Measurements (ICRU) Report 44 (1989)35, and the photon fluence can be obtained from 
a Monte Carlo simulation. 
Radioactivity A(t) at time t in a source organ can be estimated from Ri,j values and D-
shuttle dosimeter measurements to solve Eq. (4) iteratively using the maximum-likelihood 210 
expectation-maximization (MLEM) algorithm. The MLEM algorithm can be expressed by the 








                                                          (7) 
Analyzing equation (7), the MLEM algorithm can be described in three steps:  
(a) Start with an initial estimation of 𝐴𝐴𝑗𝑗(𝑡𝑡)(0) , where 𝐴𝐴𝑗𝑗(𝑡𝑡)(0)˃0 for j = 1, 2, 3… 215 
 (b) If 𝐴𝐴𝑗𝑗(𝑡𝑡)(𝑛𝑛) denotes the estimate of 𝐴𝐴𝑗𝑗(𝑡𝑡) at the nth iteration, calculate a new 𝐴𝐴𝑗𝑗(𝑡𝑡)(𝑛𝑛+1) 
using Eq. (7) 





2.D. Phantom Study 
To validate our proposed technique, we performed a phantom study to estimate 
radioactivities in fillable compartments embedded in the NEMA body phantom. This phantom 
consists of a body phantom, a lung insert, and an insert with six spheres of various diameters 
(10, 13, 17, 22, 28, and 37 mm) 37. The fillable compartments (torso cavity and six spheres) of 225 
the NEMA body phantom were filled with 18F-FDG mixed with pure water using an 800:1 
sphere-to-background radioactivity concentration ratio. Radioactivity concentrations present 
in the torso cavity and six spheres were 0.00165 MBq/mL and 1.32 MBq/mL, respectively. The 
lung insert was not used in this experiment. Eleven D-shuttle dosimeters were attached to 
the NEMA body phantom surface to obtain information on body surface doses (see Figure 5). 230 
Another D-shuttle dosimeter was placed inside the experiment room but away from the 
NEMA body phantom to obtain a natural background radiation measurement.     
  The inner volume of the torso cavity and each sphere were measured using their 
weights (filled with water) and wall thicknesses, and the radioactivity concentration of the 
18F-FDG PET radiotracer was measured with a dose calibrator (CRC®-55t Well counter, 235 
Capintec, inc). The initial radioactivity of the torso cavity and each sphere (treated as source 
organs) were calculated from the radioactivity concentration and measured inner volumes. 
Radioactivity was measured for each fillable compartment (torso cavity and six spheres) over 
the course of 110 min in two minute intervals from their initial radioactivity.  
A mathematical NEMA body phantom has been modeled using PHITS (Heavy Ion 240 
Transport Code System) Monte Carlo simulation code and was used to compute the R-values 
in Eq. (4) 37,38,39. PHITS is a general-purpose Monte Carlo particle transport code written in 
Fortran, and the recommended compiler is Intel Fortran 11.1 (or, later versions). PHITS was 
developed under collaboration between the Japan Atomic Energy Agency (JAEA), the 
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Research Organization for Information and Technology (RIST), the High Energy Accelerator 245 
Research Organization (KEK), and several other institutes in Japan. PHITS can deal with the 
transport of all particles (nucleons, nuclei, mesons, photons, and electrons) over wide energy 
ranges. D-shuttle dosimeter positions in Cartesian co-ordinates on the body surface of the 
mathematical NEMA body phantom in PHITS were determined according to the original 
positions of the D-shuttle dosimeters on the body surface of the NEMA body phantom during 250 
the phantom study. We performed a Monte Carlo simulation using 511 keV primary energy, 
60 keV-700 keV energy range, 100 energy bins, and 107 history number. PHITS simulation 
yields the photon energy fluence at each D-shuttle dosimeter position for each source organ. 
We calculated R-values at every D-shuttle dosimeter position for each source organ from the 
obtained photon energy fluence using Eq. (6).  255 
The radioactivity A(t) at each two minute interval in each source organ was estimated 
using the MLEM algorithm based on body surface doses as measured by D-shuttle dosimeters 
and the R-values obtained by PHITS simulation. A Python script was used to solve Eq. 7 
iteratively. An initial guess of 1015 Bq and a total of 50 iterations were used in the MLEM 
algorithm for estimating the radioactivity in each source organ.  260 
We also investigated the effect of the MLEM algorithmic response by increasing the 
number of iterations to validate our proposed technique. Hence, the actual cumulative 
radioactivity in each source organ over a 110-min dose measurement was calculated from the 
initial radioactivity of each source organ. The cumulative radioactivity from each source organ 







3.A. Simulation by PHITS  270 
Computational reconstruction of a NEMA body phantom is presented in Figures 6 and 
7. These figures correspond with the experimental set up in this study (see Figure 5). Figure 6 
also depicts the eleven D-shuttle dosimeter (D) positions in Cartesian co-ordinates on the 
mathematical NEMA body phantom. Figure 7 (a) depicts the coronal (XZ plane) view at Y=0 
cm in the mathematical phantom where regions 7 through 11 represent the bottom, the 275 
superior, the top lid, the phantom wall, the and torso cavity, of the NEMA body phantom, 
respectively. Figure 7 (b) also depicts the lateral (XY plane) view at Z=13.5 cm in the 
mathematical phantom, where regions 1 through 6 represent the six spheres with 37 mm, 28 
mm, 22 mm, 17 mm, 13 mm, and 10 mm inner diameters, respectively. The color schemes in 
Figure 7 depict the experimental configuration in PHITS, where red, yellow, and blue colors 280 
represent the radioactive sources, background, and polymethylmethacrylate (PMMA) 
phantom material, respectively. After performing the PHITS simulation, R-values in 
mGy/MBq.s at eleven D-shuttle dosimeter positions have been calculated from the photon 
energy fluence and mass energy absorption coefficients by solving the Eq. (6), which are 
summarized in Table 2.  285 
 
3.B. Radioactivity Estimation  
The actual initial radioactivities of the source organs were 34.7 MBq (37 mm sphere), 
15.1 MBq (28 mm sphere), 7.27 MBq (22 mm sphere), 3.26 MBq (17 mm sphere), 1.54 MBq 
(13 mm sphere), 0.697 MBq (10 mm sphere), and 15.9 MBq (torso cavity). Radioactivity was 290 
calculated from the actual initial radioactivity in each source organ at each two-minute 
interval (see Figure 8). The estimated initial radioactivity (mean with standard deviation, 
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n=55) with the present technique in each source organ is tabulated in Table 3. The lowest and 
the highest % CV values (1.21% and 36.2%) were obtained from the 28-mm sphere and 10 
mm sphere, respectively. As shown in Figure 8, the regression line was y=0.944x+0.468, and 295 
significant correlation (R2 = 0.992) was found between the actual radioactivity and the 
estimated radioactivity at each two-minute measurement interval.  
The actual and estimated cumulative radioactivities in each source organ were 21.1 
MBq.h (torso cavity), 45.9 MBq.h (37 mm sphere), 20.0 MBq.h (28 mm sphere), 9.61 MBq.h 
(22 mm sphere), 4.31 MBq.h (17 mm sphere), 2.04 MBq.h (13 mm sphere), 0.921 MBq.h (10 300 
mm sphere), and 22.4 MBq.h (torso cavity), 44.2 MBq.h (37 mm sphere), 21.1 MBq.h (28 mm 
sphere), 9.51 MBq.h (22 mm sphere), 5.57 MBq.h (17 mm sphere), 2.00 MBq.h (13 mm 
sphere), 1.17 MBq.h (10 mm sphere), respectively. The number of iterations and its effect on 
the estimated cumulative radioactivity in each source organ are shown in Figure 9. At first, 
the MLEM output increased with the number of iterations. After a certain iteration 305 
(approximately 25), the MLEM results showed a consistent cumulative radioactivity 
estimation for each source organ.  
 
4. DISCUSSION 
We proposed a new technique for estimating the internal radiation dosimetry in PET 310 
studies using multiple D-shuttle dosimeters attached on the patient body surface, and we 
performed a phantom study to validate our new technique by estimating the radioactivities 
while the fillable compartments were placed in a NEMA body phantom. Although we found 
some errors in the estimated radioactivity, as high as 28% in the 17 mm sphere and 24% in 
the 10 mm sphere, the phantom study overall showed a good correlation (R2=0.992) between 315 
the estimated and actual radioactivity, as shown in Figure 8. The average estimated and actual 
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radioactivities were well-matched in this study (see Table 3). Therefore, the effective dose 
can be reasonably estimated using our method if we consider the common tissue weighting 
factor for all seven source organs.   
Z Čemusová et al.30 reported that the Hp(10) measurements showed linear behavior 320 
regarding the dose response with the actual dose in the range of 0.12mSv to 121 mSv and 
dose rate linearity up to 1 mSv/h (Our study was within these ranges). Their study also showed 
the angular variability of D-shuttle dosimeter. In this study, we omit the angular variability of 
the D-shuttle dosimeter in the Monte Carlo simulation, assuming a point detector in the 
center of the D-shuttle dosimeter. Further improvement may be achieved if we include the 325 
geometry of the D-shuttle dosimeter in the Monte Carlo simulation. Moreover, the error 
associated with Monte Carlo simulation is a function of the number of histories and will be 
propagated to the estimated cumulative radioactivity. By increasing the number of histories 
in the Monte Carlo simulation, these errors can be reduced, although it requires more 
computing resources.  330 
 H M Deloar et al.40 has estimated cumulative radioactivities in source organs and 
internal radiation doses in target organs by the TLD method and conventional whole body PET 
imaging, and the obtained results from both methods have been compared to validate the 
TLD method. The obtained TLD results agree with the PET results, except in the pancreas and 
the heart. In their study, TLD only gives the total dose over a period of time during the 335 
experiment, thus they calculated the TLD dose for an infinite time period using the equation 
below. The following equation assumes that biological excretion and uptake is negligible, and 




𝑇𝑇𝑘𝑘(𝑡𝑡0)                                                                                                                 (8) 
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𝑇𝑇𝑘𝑘(∞) is the body surface dose for infinite time at the k’th TLD position, and 𝑇𝑇𝑘𝑘(𝑡𝑡0) is the 340 
body surface dose at the k’th TLD position during the measuring time period 𝑡𝑡0. Since the D-
shuttle dosimeter gives a TAC, we are able to estimate the cumulative radioactivity in a source 
organ more precisely. The residual cumulative radioactivity in a source organ can be estimated 
by extrapolating the measured dose data of the D-shuttle dosimeters during clinical PET study 
by utilizing a compartment model41 or using exponential fitting of the TAC42. Moreover, their 345 
study reported that the obtained cumulative radioactivity in the heart using the TLD method 
was 2.64 times higher than the results obtained from conventional PET imaging. This large 
inconsistency was due to a TLD dose response from the heart due to highly concentrated 
blood radioactivity just after the FDG injection. This radioactivity signal from blood could not 
be measured using the whole body PET because of the delayed scanning time. Since a D-350 
shuttle dosimeter gives us measurements in two minute intervals during the entire 
experiment, it is possible to detect the early phase of injected radioactivity that could not be 
measured in a PET study due to the delayed scanning time. 
Their study also reported that the obtained cumulative radioactivity in the pancreas 
from the TLD method was 1.83 times higher than the result obtained from the conventional 355 
PET imaging method. The authors concluded the reasons for this extensive inconsistency 
were 1) actual individual organ sizes had partially deviated from the MIRD organ sizes with a 
factor related to individual total weight, and 2) the TLD positions used for measurement of 
the individual body surface doses during the PET study and their positions used for the R-
matrix calculation were different. Actually, the MIRD reference phantoms are mainly 360 
established using statistics on Caucasians. But human geometries considering height, weight, 
organ shape, and volume varies between ethnicities because of diverse dietary habits, 
lifestyles, and geographic environments. In our phantom study, the mathematical NEMA body 
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phantom was modelled in Monte Carlo PHITS simulation using the geometry described in IEC 
standard 61675-139 and the data spectrum’s NEMA IEC body phantom manual37. Therefore, 365 
there was no geometric inconsistency between the experimental set up and simulated results 
by PHITS38, and D-shuttle dosimeter positions on the surface of a physical NEMA body 
phantom and their positions on the surface of a mathematical NEMA body phantom used for 
R-value calculation were the same (see Figures 5, 6, and 7). Hence, we obtained good results 
in all variants. But the R-value calculation using Formula 6 based on the MIRD reference 370 
phantom may produce bias in estimated internal dosimetry due to the mismatch of D-shuttle 
dosimeter positions and organ geometries if we apply our technique in a real patient. 
Therefore, a personalized phantom is ideal for estimating realistic internal dosimetry for R-
value calculations from the Monte Carlo simulation. Anatomical data can be obtained by 
performing computed tomography (CT) or magnetic resonance imaging (MRI) measurements, 375 
and a voxel phantom based on digital images recorded from CT or MRI is then utilized in PHITS 
(Heavy Ion Transport Code System) Monte Carlo simulation. Alternatively, we may choose 
any one of the following procedures if CT or MRI procedures are not available. First 
procedure: We may redesign the regional reference phantom (Japanese44, Korean45, or 
Taiwanese46 reference phantom) by modifying the equations of the outer body and the 380 
internal organs. The outer body dimensions can be obtained by scaling the measurements of 
the patient’s body. Based on the outer dimensions of the patient’s body, we may reconstruct 
the internal structure of the phantom using the same volumes of the internal organs of the 
regional phantom. Second procedure: As WAZA-ARI47 does, we may prepare several voxel 
phantoms that vary with age, weight, and height. H M Deloar et al.40 utilized a common 385 
mathematical phantom to compute R-values at each TLD position for all six normal volunteers 
(age 22-56 years) in their study. They found that the highest and lowest inter subject variation 
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of the absorbed dose estimate were 86% and 8.57%, for the bladder wall and nasal cavity wall, 
respectively. We may obtain less variable results for the internal radiation doses of a patient 
in the clinical PET study by modeling the phantom in the Monte Carlo simulation using any of 390 
the above-mentioned procedures. It should be noted that PHITS has already been used for 
various medical applications, such as patient dose estimation for radiotherapy and computed 
tomography examination47,48,49.  
The number of D-shuttle dosimeters must be greater than the number of source 
organs to stably estimate cumulative radioactivity. We placed the D-shuttle dosimeters 395 
randomly on the surface of the NEMA body phantom and determined the positions of the D-
shuttle dosimeter carefully against the source organ, as shown in Figure 5. However, the 
inaccurate determination of D-shuttle dosimeter positioning on the patient body surface may 
lead to inaccuracies in internal radiation dosimetry estimation in clinical PET studies. These 
may be addressed using the following ideas. First: We may use an apron or jacket that will be 400 
adjusted with the patient’s body. The location of the D-shuttle dosimeters will be marked on 
the apron or jacket, and then D-shuttle dosimeters will be attached to the identified locations 
on the apron or jacket. Second: The three-dimensional positions of D-shuttle dosimeters will 
be determined using an optical tracking system50. 
Matsumoto et al.5 has used the mathematical inverse transform method (unfolding 405 
code SAND -II)27, which does not consider the statistical features of TLD measurements when 
estimating cumulative radioactivities in the source organs, and Deloar et a.l40 reported that 
this method is highly dependent on the initial guess. Lu et al.25  has used the Jacobi linear 
inverse method to estimate the cumulative radioactivities in source organs. The Jacobi 
method can generally be used for solving a linear system where the coefficient matrix is 410 
diagonally dominant. This iterative method works fine with a well-conditioned linear system, 
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but it will fail to converge for an ill-conditioned linear system. In our proposed technique, the 
maximum-likelihood expectation-maximization (MLEM) algorithm32 was used to solve the 
dose radioactivity formula iteratively. The MLEM algorithm is widely utilized as a PET image 
reconstruction method as the observed data follows a Poisson distribution. Because a D-415 
shuttle dosimeter counts the number of photons and follows Poisson distributions, the MLEM 
algorithm is expected to be more stable provide a better internal dosimetry estimate than 
the unfolding method or the Jacobi method. In this phantom experiment, nine D-shuttle 
dosimeters were attached to the front side of the phantom, and two D-shuttle dosimeters 
were attached to the back side of the phantom. Each % CV (see Table 3) was obtained from 420 
the estimated radioactivity data in two-minute intervals over a 110-min total dose 
measurement (n=55), and each estimated radioactivity in a source organ was calculated using 
data from eleven D-shuttle dosimeters. In general, less bias and % CV value were observed 
for larger source organs in the present study (see Table 3). Interestingly, the lowest % CV 
value obtained in this study occurred for the 28 mm sphere, although the 37 mm sphere had 425 
the highest radioactivity. Because of the internal radioactivity and geometric dependency, the 
28 mm sphere contributed to a larger D-shuttle dosimeter response. The % CV value for the 
22 mm sphere was larger than the expected value. This phenomenon may have occurred 
because the distance from the D-shuttle dosimeters attached the backside of the phantom to 
the 22 mm sphere was the largest. It is clearly seen in Figure 9 that the estimated result for 430 
each source organ was almost consistent after 25 iterations in the MLEM calculations. Further 
studies are required to determine how many iterations and how many D-shuttle dosimeters 
will be needed when the MLEM method is applied in a clinical PET study.  
 In this phantom study, we validated our proposed technique for estimating 
internal dosimetry in a PET study using 18F-FDG PET radiotracer. Our new technique for 435 
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internal dosimetry may be also useful for other nuclear imaging modalities, such as single 
photon emission computed tomography (SPECT), planar scintigraphy, etc. Generally, PET 
radiotracers (11C, 13N, 15O, 18F etc.) emit higher energy gamma rays (511 keV). D-shuttle 
dosimeters were originally intended for use in the Fukushima Daiichi nuclear power plant 
accident and were optimized to detect 661.7 keV gamma rays emitted from 137Cs, which are 440 
close to PET annihilation photon energy of 551 keV. Moreover, Z Čemusová et al.30 tested the 
energy dependency of the D-shuttle dosimeter and reported that maximum Hp(10) 
underestimation of 38% and 40% was detected for radiation qualities of N-150 and N-250, 
respectively. Therefore, to use our proposed technique on SPECT radiotracers (usually less 
than 300 keV gamma rays), we may need to optimize the energy response of the D-shuttle.  445 
 
5. CONCLUSION 
In this paper, we proposed a convenient, novel, and non-invasive technique to 
estimate the internal dosimetry in a PET study using multiple D-shuttle dosimeters attached 
to the body surface of a patient. To validate our proposed technique, we performed a 450 
phantom study using a NEMA body phantom that contained six spherical radioactive sources 
and background radioactivity. The phantom study showed a good overall correlation between 
estimated and actual radioactivity.   
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FIGURE LEGENDS 
Figure 1. D-shuttle dosimeters which are capable to record every two-minute dose data in the 




Figure 2. Concept of the MIRD method. Radiation dose in ith target organ is connected to 
radioactive decay in each source organ and the so-called S-values from source organ to target 
organ. 
 605 
Figure 3. Flow chart of the proposed technique for estimating internal radiation dose in PET 
studies. 
 
Figure 4. Concept of the proposed technique. The body surface dose at the D-shuttle 
dosimeter position is connected to gamma decay in each source organ and R-values from 610 
the source organ to the D-shuttle dosimeter position. 
 
Figure 5. Experimental set up and eleven D-shuttle dosimeter (D) positions in Cartesian co-
ordinates on the surface of a NEMA body phantom for obtaining body surface doses; a) front 
side of the phantom and b) back side of the phantom. 615 
 
Figure 6. Simulated mathematical NEMA body phantom with eleven D-shuttle dosimeter (D) 
positions in Cartesian co-ordinates; a) front side of the phantom and b) back side of the 




Figure 7. a) Coronal view at Y=0 cm and b) lateral view at Z=13.5 cm of the mathematical 
NEMA body phantom in PHITS; there are six spheres, with inner diameters of 1) 37 mm, 2) 
28 mm, 3) 22 mm, 4) 17 mm, 5) 13 mm, and 6) 10 mm.     
 
Figure 8. Correlation between actual radioactivity and estimated radioactivity over 110 min 625 
of dose measurements (n=55) in the source organs. 
 
Figure 9. Number of iterations versus the cumulative radioactivity in each source organ. 
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